Purpose
|
Zomepirac, formerly marketed as Zomax tablets, was associated with fatal and near-fatal anaphylactoid reactions. The manufacturer voluntarily removed Zomax tablets from the Canadian, US, and UK markets in March 1983.
|
Characteristics
|
Source of Compound: synthetic Target: COX Receptor: Prostaglandin D2 receptor Status: USAN, INN, BAN
|
Purification
|
All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
|
Purity
|
98?%
|
Formula
|
C15H13ClNNaO3
|
Solubility
|
0.026 mg/mL in H2O
|